S&P 500
(-0.46%) 5 048.42 points
Dow Jones
(-0.98%) 38 086 points
Nasdaq
(-0.64%) 15 612 points
Oil
(0.34%) $83.85
Gas
(-4.70%) $1.561
Gold
(0.17%) $2 346.40
Silver
(0.52%) $27.50
Platinum
(1.03%) $930.00
USD/EUR
(0.09%) $0.933
USD/NOK
(0.16%) $10.97
USD/GBP
(0.09%) $0.800
USD/RUB
(0.01%) $92.18

Realtime updates for YiChang HEC ChangJiang [1558.HK]

Exchange: HKSE Sector: Pharmaceuticals Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated25 Apr 2024 @ 23:59

0.80% HKD 12.60

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 23:59):

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China...

Stats
Today's Volume 187 000
Average Volume 1.99M
Market Cap 10.72B
EPS HKD0 ( 2024-03-28 )
Last Dividend HKD0.114 ( 2020-09-29 )
Next Dividend HKD0 ( N/A )
P/E 5.16
ATR14 HKD0.0200 (0.16%)

Volume Correlation

Long: -0.13 (neutral)
Short: -0.33 (neutral)
Signal:(59.071) Neutral

YiChang HEC ChangJiang Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

YiChang HEC ChangJiang Correlation - Currency/Commodity

The country flag -0.44
( neutral )
The country flag -0.50
( weak negative )
The country flag 0.00
( neutral )
The country flag -0.08
( neutral )
The country flag 0.00
( neutral )
The country flag 0.72
( moderate )

YiChang HEC ChangJiang Financials

Annual 2023
Revenue: HKD6.29B
Gross Profit: HKD4.99B (79.21 %)
EPS: HKD2.26
Q4 2023
Revenue: HKD3.09B
Gross Profit: HKD2.42B (78.49 %)
EPS: HKD1.090
Q2 2023
Revenue: HKD3.21B
Gross Profit: HKD2.56B (79.90 %)
EPS: HKD1.170
Q4 2022
Revenue: HKD2.45B
Gross Profit: HKD1.89B (76.90 %)
EPS: HKD0.120

Financial Reports:

No articles found.

YiChang HEC ChangJiang Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

YiChang HEC ChangJiang Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.02 - good (80.17%) | Divividend Growth Potential Score: 4.29 - Potential for dividend initiation, but uncertain (14.18%)
Information
First Dividend HKD0.0885 2016-06-08
Last Dividend HKD0.114 2020-09-29
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 9 --
Total Paid Out HKD2.08 --
Avg. Dividend % Per Year 0.00% --
Score 2.94 --
Div. Sustainability Score 8.02
Div.Growth Potential Score 4.29
Div. Directional Score 6.15 --
Next Divdend (Est)
(2024-07-24)
HKD0 Estimate 0.00 %
Dividend Stability
0.06 Very Bad
Dividend Score
2.94
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
2388.HK Ex Dividend Knight 2023-09-14 Semi-Annually 0 0.00%
1378.HK Ex Dividend Knight 2023-11-16 Annually 0 0.00%
0440.HK Ex Dividend Knight 2023-09-07 Semi-Annually 0 0.00%
6818.HK Ex Dividend Junior 2023-06-26 Annually 0 0.00%
1929.HK Ex Dividend Knight 2023-07-12 Semi-Annually 0 0.00%
0956.HK Ex Dividend Junior 2023-05-18 Annually 0 0.00%
0086.HK Ex Dividend Junior 2023-08-31 Semi-Annually 0 0.00%
3306.HK Ex Dividend Knight 2023-10-30 Annually 0 0.00%
1523.HK Ex Dividend Knight 2023-08-09 Semi-Annually 0 0.00%
0573.HK Ex Dividend Junior 2023-10-05 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.3171.5003.675.50[0 - 0.5]
returnOnAssetsTTM0.1561.2004.795.75[0 - 0.3]
returnOnEquityTTM0.2681.5008.1310.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.3970.8008.016.41[1 - 3]
quickRatioTTM0.8690.8009.597.67[0.8 - 2.5]
cashRatioTTM0.3871.5008.9610.00[0.2 - 2]
debtRatioTTM0.205-1.5006.59-9.88[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM1.4152.009.5310.00[0 - 30]
freeCashFlowPerShareTTM1.1702.009.4210.00[0 - 20]
debtEquityRatioTTM0.329-1.5008.68-10.00[0 - 2.5]
grossProfitMarginTTM0.7921.0000.1320.132[0.2 - 0.8]
operatingProfitMarginTTM-1.1411.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM0.4771.0008.468.46[0.2 - 2]
assetTurnoverTTM0.4940.800-0.0406-0.0325[0.5 - 2]
Total Score8.02

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM5.041.0009.590[1 - 100]
returnOnEquityTTM0.2682.508.8010.00[0.1 - 1.5]
freeCashFlowPerShareTTM1.1702.009.6110.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM1.4152.009.5310.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.07631.500-2.820[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1981.0007.560[0.1 - 0.5]
Total Score4.29

YiChang HEC ChangJiang

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators